Active Biotech AB (ACTI) — Net Asset Quality Index
Active Biotech AB (ACTI) has a Net Asset Quality Index of 26.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr17.00 Million minus total liabilities of Skr12.50 Million yields net assets of Skr4.50 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Active Biotech AB (ACTI) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Active Biotech AB Net Asset Quality Index Over Time (2000–2024)
This chart shows how Active Biotech AB's Net Asset Quality Index has evolved across 25 annual periods from 2000 to 2024. As of September 2025, the index stands at 26.5%, representing net assets of Skr4.50 Million against total assets of Skr17.00 Million SEK. See Active Biotech AB working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Active Biotech AB (2000–2024)
The table below presents the year-by-year Net Asset Quality Index for Active Biotech AB from 2000 to 2024, covering 25 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ACTI market cap.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 74.2% | Skr32.07 Million | Skr43.20 Million | Skr11.13 Million | ▲ +4.6 pp |
| 2023 | 69.6% | Skr30.67 Million | Skr44.05 Million | Skr13.38 Million | ▲ +2.0 pp |
| 2022 | 67.7% | Skr34.51 Million | Skr51.01 Million | Skr16.49 Million | ▼ -14.5 pp |
| 2021 | 82.2% | Skr46.67 Million | Skr56.80 Million | Skr10.13 Million | ▲ +13.4 pp |
| 2020 | 68.8% | Skr22.11 Million | Skr32.16 Million | Skr10.04 Million | ▼ -11.6 pp |
| 2019 | 80.3% | Skr53.78 Million | Skr66.95 Million | Skr13.17 Million | ▲ +51.3 pp |
| 2018 | 29.1% | Skr87.92 Million | Skr302.43 Million | Skr214.52 Million | ▲ +3.5 pp |
| 2017 | 25.6% | Skr77.68 Million | Skr303.81 Million | Skr226.14 Million | ▼ -18.6 pp |
| 2016 | 44.2% | Skr182.56 Million | Skr412.88 Million | Skr230.32 Million | ▲ +4.0 pp |
| 2015 | 40.2% | Skr180.60 Million | Skr449.44 Million | Skr268.84 Million | ▼ -15.9 pp |
| 2014 | 56.1% | Skr405.31 Million | Skr722.52 Million | Skr317.21 Million | ▲ +3.3 pp |
| 2013 | 52.8% | Skr405.41 Million | Skr767.81 Million | Skr362.40 Million | ▲ +4.0 pp |
| 2012 | 48.8% | Skr339.92 Million | Skr696.74 Million | Skr356.82 Million | ▼ -9.7 pp |
| 2011 | 58.5% | Skr501.99 Million | Skr858.52 Million | Skr356.53 Million | ▲ +22.3 pp |
| 2010 | 36.1% | Skr181.76 Million | Skr503.10 Million | Skr321.34 Million | ▼ -1.7 pp |
| 2009 | 37.8% | Skr188.64 Million | Skr498.50 Million | Skr309.86 Million | ▲ +3.2 pp |
| 2008 | 34.6% | Skr163.61 Million | Skr472.95 Million | Skr309.34 Million | ▼ -4.1 pp |
| 2007 | 38.7% | Skr189.57 Million | Skr489.54 Million | Skr299.97 Million | ▲ +25.7 pp |
| 2006 | 13.1% | Skr60.36 Million | Skr462.40 Million | Skr402.04 Million | ▼ -18.1 pp |
| 2005 | 31.1% | Skr176.81 Million | Skr567.86 Million | Skr391.05 Million | ▼ -20.7 pp |
| 2004 | 51.9% | Skr162.30 Million | Skr312.89 Million | Skr150.59 Million | ▼ -32.0 pp |
| 2003 | 83.8% | Skr289.58 Million | Skr345.40 Million | Skr55.82 Million | ▲ +2.5 pp |
| 2002 | 81.3% | Skr380.27 Million | Skr467.50 Million | Skr87.24 Million | ▼ -9.4 pp |
| 2001 | 90.8% | Skr678.78 Million | Skr747.74 Million | Skr68.96 Million | ▲ +16.4 pp |
| 2000 | 74.3% | Skr646.03 Million | Skr868.95 Million | Skr222.92 Million | — |